Exservan(riluzole)
Exservan 50 MG Oral Film
NO BOXED WARNING
Dosage & Administration
Dosage & Administration
drug label
Exservan Prescribing Information
pharmacy
Exservan Preferred Pharmacy
financial assistance
Exservan Financial Assistance Options
patient education
Exservan Patient Education
Getting started on Exservan
To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link
Patient toolkit
Other resources
people also ask
Exservan FAQs
What is the risk of using EXSERVAN (riluzole) during pregnancy?There are no studies of riluzole in pregnant women, but animal studies suggest potential developmental toxicity at clinically relevant doses. Women should be informed of possible fetal risks associated with using EXSERVAN during pregnancy.
What are the findings from animal studies regarding riluzole use in pregnancy?Oral administration of riluzole to pregnant rats and rabbits during organogenesis resulted in decreased fetal growth and increased embryofetal mortality at higher doses. Maternal toxicity was observed at the highest doses tested.
Is there information about riluzole in breast milk and its effects on breastfeeding infants?There's no data on the presence of riluzole in human milk or its effects on breastfed infants. However, riluzole or its metabolites have been detected in the milk of lactating rats. Consideration should be given to breastfeeding benefits alongside potential adverse effects of EXSERVAN on the infant.
What is known about riluzole's impact on fertility in rats?Oral administration of riluzole in rats led to decreased fertility indices and increased embryolethality.
Is EXSERVAN safe and effective for pediatric use?Safety and effectiveness in pediatric patients have not been established for EXSERVAN.
How does riluzole perform in elderly patients?In clinical studies, no significant differences in safety or effectiveness were observed between elderly and younger patients. However, some older individuals might have increased sensitivity.
What should be considered for patients with hepatic impairment when using EXSERVAN?Patients with mild or moderate hepatic impairment may have increased risk of adverse reactions due to elevated riluzole exposure. EXSERVAN is not recommended for patients with certain baseline elevations in serum aminotransferases or evidence of liver dysfunction.
What's unique about riluzole use in Japanese patients?Japanese patients might have higher riluzole concentrations, potentially leading to a higher risk of adverse reactions.
FAQ Data Source